Ryan Hartman Appointed To Chief Commercial Officer Of Trice Medical

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Ryan Hartman brings with him over twenty years of healthcare experience, of which the last nineteen years were with Boston Scientific.

He received his Bachelor of Arts from SUNY, New Paltz and his Master of Science from New School University.

He will be responsible for developing and executing the Global Marketing strategy including; Health Economics and Reimbursement, Clinical Strategy and Product Development across Trice Medical’s growing, innovative business.

Over the course of his career, Mr. Hartman advanced through multiple leadership roles within Sales, Marketing and Market Development.  In his most recent position as Vice President for Single-Use Scopes and Global Markets, Mr. Hartman was instrumental in positioning Boston Scientific as a global leader in the Gastrointestinal Single Use Endoscopy space, where he led a team that would be the first to launch several disruptive disposable endoscopes.

Trice Medical is known for its disruptive imaging technology that enables orthopedic procedures to be performed on its portable, tablet-based system. Trice developed the world’s first and only platform that combines a disposable needle camera (mi-eye™) with a high-quality 15mghz ultrasound transducer (mi-ultra™).

In 2020, Trice launched a fully-disposable endoscopic carpal tunnel system with the disposable mi-eye angled camera, making Trice the first company in the world to enable surgeons to perform this procedure anywhere: in the operating room; a procedure room; or in the office.

In 2021, Trice acquired Tenex Health, whose cutting-edge, minimally invasive technology improves overall functionality and significantly decreases pain, by precisely targeting and removing damaged tissue and bone without the need for conventional surgery.

“Ryan is a visionary, innovative, thoughtful and patient centric leader in the industry. His background with regards to understanding the market opportunities for small, disposable cameras is a perfect match for where our business is headed,” said CEO and President, Mark Foster. “Trice is building a large business in small procedures and we are looking forward to Ryan’s contributions.”

“We are at the very beginning of a massive wave of change in the way disposable cameras will be used, to unlock value throughout the global healthcare world.  Many of these future innovations will enable healthcare providers to deliver better patient outcomes, with more efficiency.  I am very excited to join the talented team at Trice to help bring their vision to life,” said Chief Commercial Officer, Ryan Hartman.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.